Cargando…

Development of a Nuclear Morphometric Signature for Prostate Cancer Risk in Negative Biopsies

BACKGROUND: Our objective was to develop and validate a multi-feature nuclear score based on image analysis of direct DNA staining, and to test its association with field effects and subsequent detection of prostate cancer (PCa) in benign biopsies. METHODS: Tissue sections from 39 prostatectomies we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gann, Peter H., Deaton, Ryan, Amatya, Anup, Mohnani, Mahesh, Rueter, Erika Enk, Yang, Yirong, Ananthanarayanan, Viju
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3724855/ https://www.ncbi.nlm.nih.gov/pubmed/23922715 http://dx.doi.org/10.1371/journal.pone.0069457

Ejemplares similares

Alteration of proliferation and apoptotic markers in normal and premalignant tissue associated with prostate cancer
por: Ananthanarayanan, Vijayalakshmi, et al.
Publicado: (2006)

High incidence of triple negative breast cancers following pregnancy and an associated gene expression signature
por: Asztalos, Szilard, et al.
Publicado: (2015)

Arylsulfatase B (N-Acetylgalactosamine-4-Sulfatase): Potential Role as a Biomarker in Prostate Cancer
por: Feferman, Leo, et al.
Publicado: (2013)

Retinoid and carotenoid status in serum and liver among patients at high-risk for liver cancer
por: Kataria, Yachana, et al.
Publicado: (2016)

GPX1 Localizes to the Nucleus in Prostate Epithelium and its Levels are not Associated with Prostate Cancer Recurrence
por: Ekoue, Dede N., et al.
Publicado: (2018)

Deep learning–based molecular morphometrics for kidney biopsies
por: Zimmermann, Marina, et al.
Publicado: (2021)

Indications for a second prostate biopsy in patients suspected with prostate cancer after an initial negative prostate biopsy
por: Lee, Kwang Suk, et al.
Publicado: (2017)

Association of High miR-182 Levels with Low-Risk Prostate Cancer
por: Baumann, Bethany, et al.
Publicado: (2019)

Evidence That Selenium Binding Protein 1 Is a Tumor Suppressor in Prostate Cancer
por: Ansong, Emmanuel, et al.
Publicado: (2015)

Nuclear Morphometric Analysis (NMA): Screening of Senescence, Apoptosis and Nuclear Irregularities
por: Filippi-Chiela, Eduardo C., et al.
Publicado: (2012)

The Reproducibility of Nuclear Morphometric Measurements in Invasive Breast Carcinoma
por: Kronqvist, Pauliina, et al.
Publicado: (1997)

Validation of Morphometric Analyses of Small-Intestinal Biopsy Readouts in Celiac Disease
por: Taavela, Juha, et al.
Publicado: (2013)

Targeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer
por: Kim, Yunee, et al.
Publicado: (2016)

Combining targeted and systematic prostate biopsy improves prostate cancer detection and correlation with the whole mount histopathology in biopsy naïve and previous negative biopsy patients
por: Mischinger, Johannes, et al.
Publicado: (2022)

Transcriptional and cellular signatures of cortical morphometric remodelling in chronic pain
por: Martins, Daniel, et al.
Publicado: (2022)

The Role of TURP in the Detection of Prostate Cancer in BPH Patients with Previously Negative Prostate Biopsy
por: Kim, Dae Keun, et al.
Publicado: (2010)

Magnetic resonance imaging detection of prostate cancer in men with previous negative prostate biopsy
por: Truong, Matthew, et al.
Publicado: (2017)

DNA methylation in repeat negative prostate biopsies as a marker of missed prostate cancer
por: Fiano, Valentina, et al.
Publicado: (2019)

Machine Learning for Nuclear Mechano-Morphometric Biomarkers in Cancer Diagnosis
por: Radhakrishnan, Adityanarayanan, et al.
Publicado: (2017)

Histopathological and Morphometric Study of Fibrosis and Nuclear Pleomorphism in Dilated Cardiomyopathy
por: MITRUȚ, R, et al.
Publicado: (2019)

Biomarkers in previous histologically negative prostate biopsies can be helpful in repeat biopsy decision‐making processes
por: Long, Xingbo, et al.
Publicado: (2020)

Serum testosterone as a biomarker for second prostatic biopsy in men with negative first biopsy for prostatic cancer and PSA>4ng/mL, or with PIN biopsy result
por: Fiamegos, Alexandros, et al.
Publicado: (2016)

Detection of prostate cancer using prostate imaging reporting and data system score and prostate-specific antigen density in biopsy-naive and prior biopsy-negative patients
por: Ryoo, Hyunsoo, et al.
Publicado: (2020)

Correlations of SELENOF and SELENOP genotypes with serum selenium levels and prostate cancer
por: Ekoue, Dede N., et al.
Publicado: (2018)

Combined T2 and diffusion-weighted MR imaging with template prostate biopsies in men suspected with prostate cancer but negative transrectal ultrasound-guided biopsies
por: Sheikh, Nissar, et al.
Publicado: (2016)

Safety of 12 core transrectal ultrasound guided prostate biopsy in patients on aspirin
por: Vasudeva, Pawan, et al.
Publicado: (2015)

Predictors of clinically significant prostate cancer in biopsy-naïve and prior negative biopsy men with a negative prostate MRI: improving MRI-based screening with a novel risk calculator
por: van Riel, Luigi A.M.J.G., et al.
Publicado: (2022)

Morphometrical Analysis of Nuclear Abnormality of Tubular Tumors of the Stomach with Image Processing
por: Ishido, Tatsuya, et al.
Publicado: (1992)

Analysis of risk factors for determining the need for prostate biopsy in patients with negative MRI
por: Liang, Linghui, et al.
Publicado: (2021)

Risk of progression following a negative biopsy in prostate cancer active surveillance
por: Beckmann, Kerri, et al.
Publicado: (2022)

The Influence of Serum Prostate-Specific Antigen on the Accuracy of Magnetic Resonance Imaging Targeted Biopsy versus Saturation Biopsy in Patients with Previous Negative Biopsy
por: Chang, Chao-Hsiang, et al.
Publicado: (2017)

High-risk prostate cancer: value of multi-modality 3T MRI-guided biopsies after previous negative biopsies
por: Fütterer, Jurgen J., et al.
Publicado: (2011)

Detection Rate of Prostate Cancer in Repeat Biopsy after an Initial Negative Magnetic Resonance Imaging/Ultrasound-Guided Biopsy
por: Görtz, Magdalena, et al.
Publicado: (2023)

Statistical Methods for Drug Safety
por: Gibbons, Robert, et al.
Publicado: (2015)

Repeat Prostate Biopsy Strategies after Initial Negative Biopsy: Meta-Regression Comparing Cancer Detection of Transperineal, Transrectal Saturation and MRI Guided Biopsy
por: Nelson, Adam W., et al.
Publicado: (2013)

Clinical and histopathological study of renal biopsy in Nepalese children: A single center experience
por: Amatya, Manim, et al.
Publicado: (2022)

Mechanism underlying the negative effect of prostate volume on the outcome of extensive transperineal ultrasound‐guided template prostate biopsy
por: Demura, Takayoshi, et al.
Publicado: (2018)

Systematic and MRI-Cognitive Targeted Transperineal Prostate Biopsy Accuracy in Detecting Clinically Significant Prostate Cancer after Previous Negative Biopsy and Persisting Suspicion of Malignancy
por: Vėželis, Alvydas, et al.
Publicado: (2021)

Morphometric grading of invasive ductal breast cancer. I. Thresholds for nuclear grade.
por: Kronqvist, P., et al.
Publicado: (1998)

Nuclear morphometric features in benign breast tissue and risk of subsequent breast cancer
por: Cui, Yan, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_snr8qef5vc81g37hpt4sv02362